President donald trump has unveiled a deal with drugmakers eli lilly and novo nordisk to expand coverage and reduce prices for their popular obesity treatments zepbound and wegovy. President donald trump unveiled a deal thursday with drugmakers eli lilly and novo nordisk to expand coverage and reduce prices for their popular obesity treatments zepbound and wegovy The historic reduction in prices negotiated by president trump will enable medicare and medicaid to cover obesity drugs for adults at a dramatically lower cost to taxpayers than that proposed by.
President donald trump announced deals with eli lilly and novo nordisk to slash the prices of some of their obesity drugs, including upcoming pills, in a landmark effort to expand access to the. The deal, with eli lilly and novo nordisk, is expected to lower the price of obesity drugs to between $149 and $350 per month in certain cases, officials said. Eli lilly and novo nordisk to lower obesity drug prices and expand medicare coverage, addressing high prescription costs for the popular drugs.
